MedTrace Logo

Microvascular and Metabolic Effects of High-intensity Interval Exercise Training

NCT03236285 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-03-13

No results posted yet for this study

Summary

The study investigates the effects of high intensity interval training (HIIT) versus continuous training (CT), combined or not with fasting, on capillary density, microvascular function, cardiometabolic risk markers, functional capacity, and quality of life, in overweight or obese sedentary women with cardiometabolic risk factors. The use of HIIT could promote greater improvements in these parameters than CT. Furthermore, the positive effects of exercise may increase when it is performed in the fasting state, compared to exercise performed in the fed state.

Conditions

Interventions

BEHAVIORAL

High-intensity interval exercise training in the fed state

High-intensity interval exercise training in the fed state

BEHAVIORAL

Continous exercise training in the fed state

Continous exercise training in the fed state

BEHAVIORAL

High-intensity interval exercise training in the fasting state

High-intensity interval exercise training in the fasting state

BEHAVIORAL

Continous exercise training in the fasting state

Continous exercise training in the fasting state

Sponsors & Collaborators

  • National Institute of Cardiology, Laranjeiras, Brazil

    lead OTHER_GOV

Principal Investigators

  • EDUARDO V TIBIRICA, MD, PhD · National Innstitute of Cardiology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-20
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03236285 on ClinicalTrials.gov